Ignite Creation Date:
2024-05-06 @ 9:49 AM
Last Modification Date:
2024-10-26 @ 12:20 PM
Study NCT ID:
NCT03087448
Status:
TERMINATED
Last Update Posted:
2022-12-27
First Post:
2017-02-10
Brief Title:
Ceritinib Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer NSCLC
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-10
First Submit QC Date:
March 16 2017
Study First Post Date:
2017-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-22
Last Update Post Date:
2022-12-27
Last Update Post Date Type:
ACTUAL